Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2000-10-21
2002-12-03
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S460000, C514S461000, C514S470000, C514S475000, C514S813000
Reexamination Certificate
active
06489357
ABSTRACT:
BACKGROUND
Despite the consensus that nicotine is the compound responsible for the addictive properties of cigarettes, other factors may contribute to this addiction. Besides nicotine, tobacco contains thousands of other compounds among which there is a family of cyclic diterpenoids called cembranoids. Cyclic diterpenoids are also found in marine invertebrates, specifically Gorgonian species (soft corals).
Cembranoids are found in both tobacco leaves and flowers. Their content varies considerably with the tobacco species, constituting on the average about 1% (w/w) of green leaves. By comparison, nicotine content in cigarette tobacco is about 1-3%. The most abundant tobacco cembranoids are (1S,2E,4R,6R,7E,11E)-cembra-2,7,11-triene-4,6-diol (also termed 4R-cembratriene) and its diasteroisomer (1S,2E,4S,6R,7E,11E)-cembra-2,7,11-triene-4,6-diol (also termed 4S-cembratriene). Both of these compounds are shown in FIG.
1
. These compounds are thought to be the precursors of most of the over seventy currently known tobacco cembranoids. Relatively few biological effects of tobacco cembranoids have been described. These few described biological effects include regulation of plant growth, inhibition of tumor growth, inhibition of aldose reductase and of prostaglandin synthesis.
SUMMARY OF THE INVENTION
According to another aspect of the invention, administering cembranoids to a living host reduces sensitization to nicotine.
According to further aspects of the invention, the living host is sensitized to nicotine by regular administration of nicotine to the living host. The cembranoids are administered after the regular administration of nicotine to the living host. The cembranoids may all be the same compound or may be a plurality of different compounds, including eunicin, eupalmerin acetate, 12,13-bisepieupalmerin, 4S-cembratriene and 4R-cembratriene.
According to one aspect of the invention, the cembranoids are administered in a dose of approximately six milligrams of cembranoid per kilogram of host.
According to another aspect of the invention, the cembranoid is administered in a dose of approximately, or that does not exceed, a milligram of cembranoid per kilogram of host.
According to still further aspects of the invention, the living host is a mammal.
REFERENCES:
patent: 4789640 (1988-12-01), Lindstrom
patent: 4835162 (1989-05-01), Abood
patent: 4906794 (1990-03-01), Umezu et al.
patent: 5039671 (1991-08-01), Baggiolini et al.
patent: 5041389 (1991-08-01), Lindstrom
patent: 5248690 (1993-09-01), Caldwel et al.
patent: 5278176 (1994-01-01), Lin et al.
patent: 5399575 (1995-03-01), Friebe et al.
patent: 5418229 (1995-05-01), Alker et al.
patent: 5591590 (1997-01-01), Heinemann et al.
patent: 5594011 (1997-01-01), McDonald et al.
patent: 5599709 (1997-02-01), Lindstrom et al.
patent: 6204289 (2001-03-01), Eterovic et al.
patent: 0 258 082 (1998-03-01), None
patent: 0 271 387 (1998-03-01), None
V. A. Eterovic—Caribbean Cembranoids are Noncompetitive Inhibitors of the Nicotinic Acetylcholine Receptors—Abstract No. 52—1991.
V. A. Eterovic—Cembranoids from Eunicea: A New Group of Noncompetitive Inhibitors of the Nicotinic Acetylcholine Receptor(AchR)—Abstract No. 53—1992.
V. A. Eterovic—Differences in the Action of Noncompetitive Inhibitors of Muscle and Electric Organ Acetylcholine Receptors—Abstract No. 55—1992.
O. R. Pagan, et al.—Inhibition of [3H]Phencyclidine Binding to the Nicotinic Acetylcholine Receptor by Cembranoids from Gorgonians—Abstract Bi, 59—1992.
R. M. Hann, et al.—The Acetylcholine Receptor: Binding Sites for Competitive and Noncompetitive Inhibitors—Abstract No. 60—1993.
Vesna A. Eterovic, et al.—Diterpenoids from Caribbean Gorgonians Act as Noncompetitive Inhibitors of the Nicotinic Acetylcholine Receptor—Cellular and Molecular Neurobiology, vol. 13, No. 2, 1993, pp. 99-110.
V. A. Eterovic, et al.—The Ion Channel of Muscle and Electric Organ Acetylcholine Receptors; Differing Affinities for Noncompetitive Inhibitors—Cellular and Molecular Neurobiology, vol. 13, No. 1, 1993, pp. 111-121.
R. M. Hann, et al.—The Biological Actions of Gorgonian Cembranoids on the Central Nervous System and the Peripheral Acetylcholine Receptor—Abstract No. 62—1993.
V. A. Eterovic, et al.—Effect of Cembranoids on Neuronal Acetylcholine Receptors—Abstract No. 65—1993.
R. Lu, et al.—New Cembranoid Inhibitors or the Nicotinic Acetylcholine Receptor: Structure-Function Relationships—Abstract No. 66—1993.
R. M. Hann, et al.—The Biological Actions of Gorgonian Cembranoids on the Central Nervous System and the Peripheral Acetylcholine Receptor—Abstract—1993.
R. M. Hann, et al.—Further Characterization of how Cembranoids Inhibit the Acetylcholine Receptor—Abstract No. 73—1994.
Vesna Ana Eterovic, et al.—Cembranoids Inhibit Neuronal Acetylcholine Receptors—Abstract—Society for Neuroscience—1994.
Richard M. Hann, et al.—The a-Conotoxins GI and MI Distinguish between the Nicotinic Acetylcholine Receptor Agonist Sites while SI Does Not—Article—Biochemistry Magazine—1994.
R. M. Hann, et al.—Affinities of Gorgonian Cembranoids for the Phencyclidine High-Affinity Binding Site on the Nicotinic Acetylcholine Receptor—Abstract No. 80—1995.
R. M. Hann, et al.—The Gorgonian Cembranoid Binding Site on the Nicotinic Acetylcholine Receptor—Abstract No. 81—1995.
V. A. Eterovic—The Nicotinic Acetylcholine Receptor: Inhibitor Tales—Abstract No. 83—1995.
R. M. Hann, et al.—Affinities of New Cembranoids for the Nicotinic Acetylcholine Receptor—Abstract No. 86—Society for Neuroscience—1995.
O. R. Pagan, et al.—Inhibition of[3H]—Phencyclidine Binding to the Nicotinic Acetylcholine Receptor by Gorgonian-derived Diterpenoids—Abstract No. 88—1995.
Vesna A. Eterovic, et al.—Neuroscience Research—Noncompetitive Inhibitors of the Acetylcholine Receptor Help Paint a Picture of its Ion Channel—PRHSJ vol. 14, No. 3, Sep., 1995, pp. 199-209.
R.M. Hann, et al.—Gorgonian Cembranoids from Puerto Rico as Noncompetitive Inhibitors of the Nicotinic Acetylcholine Receptor—Abstract No. 89—1996.
Richard M. Hann, et al. —Hydrophobicity as an Affinity Factor for Cembranoid Binding to the Nicotinic Acetylcholine Receptor—Abstract No. 95—1996.
V. A. Eterovic, et al.—The Noncompetitive Inhibitors Domain of the Nicotinic Acetylcholine Receptor—Abstract—1997.
Misty Jeanne Eaton, et al.—&bgr;T10′A and &bgr;T10′lMutations in the M2 Region of Nicotinic Receptors Alter the Potency of Phencyclidine, but not Cembranoid Pseudoplexauric Acid Methyl Ester.—Abstract No. 16—1998.
Y. Nicolau, et al.—Behavioral Effects of Cembranoids: Evidence of In Vivo Central Nicotinic Action—Abstract No. 25—1998.
Oné R. Pagán, et al. —A Model for the Relationship between the Local Anesthetic, General Anesthetic and Cembranoid Binding Sites on the Torpedo Nicotinic Acetylcholine Receptor—Abstract No. 26—1998.
Richard M. Hann, et al.—Characterization of Cembranoid Interaction with the Nicotinic Acetylcholine Receptor—The Journal of Pharmacology and Experimental Therapeutics—1998—pp. 253-260.
P. A. Ferchmin, et al—Coral and Tobacco Cembranoids Inhibit the Expression of Nicotine Sensitization of Exploratory Activity in Rats—Abstract—1999.
Oné Reynaldo Pagán, et al. —Mutually Exclusively Binding of Anesthetic Agents and Gorgonian Cembranoids to the Nicotinic Acetylcholine Receptor—Abstract—1998.
Database WPI, Section Ch. Week 9533, Derwent Publications Ltd., London, GP; AN 95-248365, XP-002080455 (Abstract) 1997.
Hahn R. M., et al.—Characterization of cembranoid interaction with the nicotinic acetylcholine receptor. J. Pharmac. Exp. Ther. 287:253-260., 1998.
Pagan, O. R., et al.—Effect of cembranoids and anesthetic agents on[3H]-tenocyclidine binding to the nicotinic acetylcholine receptor from Torpedo Californica, M. S. Tesis, University of Puerto Rico, Medicinal Sciences Campus, San Juan, Puerto Rico; 1998.
Picciotto M., et al.—Acetylcholine receptors containing the &bgr;2 subunit are involved in the reinforcing properties of nicotine. Nature, 391: 173-177, 1998.
Biello, M., et al.—Determination of Cembranoids in Cigarette Smoke
Eterovic Vesna A.
Ferchmin Pedro A.
Hann Richard M.
Pagan One R.
Rodriguez Abimael D.
Krass Frederick
Patent Law Offices of Heath W. Hoglund
University of Puerto Rico
LandOfFree
Tobacco cembranoids block the expression of the behavioral... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tobacco cembranoids block the expression of the behavioral..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tobacco cembranoids block the expression of the behavioral... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2994422